Integrated Diagnostics Holdings PLC (LSE:IDHC) Share Price

Company Profile

Business description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
Contact
12 Castle Street
St HelierJE2 3RT
JEY
T: +44 1534847000
https://www.idhcorp.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
7,137

Recommended

ETFs took centre stage in June alongside renewed interest in beaten down growth names.

Tyger Fitzpatrick | 13 July 2026

A cooling gold price sees fair value cuts across the board.

Jon Mills, CFA | 13 July 2026

Growth has slowed amid increased competition for viewers and content.

Brian Han | 09 July 2026

Index	Last price	Change	% Change
All Ordinaries	9,001.30	3.70	0.04%
CAC 40	8,366.85	2.20	0.03%
DAX 40	25,144.38	30.13	0.12%
Dow JONES (US)	52,414.61	84.03	-0.16%
FTSE 100	10,529.39	31.10	0.30%
HKSE	24,340.73	127.01	0.52%
NASDAQ	26,112.88	239.71	0.93%
Nikkei 225	67,743.50	500.77	0.74%
NZX 50 Index	13,651.22	71.98	-0.52%
S&P 500	7,542.83	27.49	0.37%
S&P/ASX 200	8,808.50	4.80	0.05%
SSE Composite Index	3,967.13	53.33	1.36%